- $37.03m
- $31.02m
- $56.65m
Brief: CVRx Announces Availability Of Additional Data Supporting Long-Term Benefits Of Barostim
U.S. RESEARCH ROUNDUP-Amerant Bancorp, IBM, Union Pacific
CVRx Inc reports results for the quarter ended in December - Earnings Summary
CVRx Inc expected to post a loss of 54 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-American Water Works Company, Home Depot, Lowe's
Brief: CVRx Reports Prelim Q4 and Fiscal Year 2023 Financial Results
U.S. STOCKS ON THE MOVE-APA, Etsy, Global Gas
U.S. STOCKS ON THE MOVE-Carnival corp, Exxon Mobil, Vince Holding
CVRx rises after FDA clears expanded label for heart implant device
Brief: CVRx Receives FDA Approval For Expanded Labeling Of Barostim
Brief: CVRX Gives Innovatus Life Sciences Fund I LP Borrowed $15 mln Under Second Tranche Of Term Loan Facility
U.S. STOCKS ON THE MOVE-US banks, Cooper-Standard, Udemy
U.S. STOCKS ON THE MOVE-Uber, CVRx, Expedia Group
CVRx up as heart implant usage prospects benefit from CMS decision
U.S. RESEARCH ROUNDUP-Caterpillar, Intel, Yelp
CVRx Inc reports results for the quarter ended in September - Earnings Summary
Brief: CVRx Q3 EPS USD -0.43
CVRx Inc expected to post a loss of 58 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Mainstreet Bancshares, Stoke Therapeutics, Visa